AstraZenecas New Obesity Drug AZD6234 Approved for Clinical Trials in China
| BIGUX Fund | USD 26.96 0.11 0.41% |
Slightly above 61% of Baron Intl's investor base is looking to short. The analysis of overall sentiment of trading Baron Intl Growth mutual fund suggests that many investors are alarmed at this time. Baron Intl's investing sentiment can be driven by a variety of factors including economic data, Baron Intl's earnings reports, geopolitical events, and overall market trends.
Baron |
The China National Medical Products Administration has approved AstraZenecas new drug, AZD6234, for clinical trials. This peptide-based medication is des
Read at gurufocus.com
 |
Baron Intl Fundamental Analysis
We analyze Baron Intl's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baron Intl using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baron Intl based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Annual Yield
Annual Yield Comparative Analysis
Baron Intl is fifth largest fund in annual yield among similar funds. Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Baron Intl Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Baron Intl mutual fund to make a market-neutral strategy. Peer analysis of Baron Intl could also be used in its relative valuation, which is a method of valuing Baron Intl by comparing valuation metrics with similar companies.
Peers
Baron Intl Related Equities
| BRIUX | Baron Real | 0.42 | ||||
| BRIFX | Baron Real | 0.42 | ||||
| BIGUX | Baron Intl | 0.41 | ||||
| BREUX | Baron Real | 0.65 | ||||
| BARUX | Baron Asset | 0.74 | ||||
| BDAUX | Baron Durable | 1.09 | ||||
| BSCUX | Baron Small | 1.16 | ||||
| BDFUX | Baron Discovery | 1.20 | ||||
| BIOUX | Baron Opportunity | 1.47 |
Other Information on Investing in Baron Mutual Fund
Baron Intl financial ratios help investors to determine whether Baron Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Baron with respect to the benefits of owning Baron Intl security.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |